Synaptogenix Inc (SNPX)

[runncoach]

I honestly don't know how the bryology X situation will play out. My feeling is it was set up to allow massive amounts of research on HIV/Cancer and other indications that aren't neural while they make money off of us to fund that research through our license deal. That's a guess though. I mean their co-founder was our founder so anything obviously could happen. Synthetic bryostatin is of little to no concern now and that's a big deal.

Biostudent asked a week or two ago about what might move the stock between now and confirmation trial results. That is a very legit question obviously. So far we only got what I would consider "word of mouth" data from an obviously biased source, Dr Alkon. He said the data will be published. If it is as black and white between non/memantine patients I would not want to be out of this stock on that publication. That might be the event that sets the stage for a 200 million dollar valuation while we await the confirmation results. I have zero idea when that would be published whether before or after the new trial starts so just trying to wait patiently here.

It's a shame so many took a hit last year on data that was only 10% complete. IMO a lot of folks have been proven wrong over the last year. The breadcrumbs were there but don't really help when some were so quick to knock everything about a trial that wasn't set up for anything but an exploratory trial. What is VERY interesting to me is that although this drug seems to be near slam dunk to treat genetic alz patients, the company hasn't jumped to try to claim to treat some sub population or at least in the way that most companies do. The company is certain they can treat any alzheimer's patient who isn't taking memantine. That's much more important than trying to target a much smaller sub group, which in and of itself would be great news as well. JMHO